Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations.
| Image |  |
|---|---|
| Description | scientific article published on 5 March 2018 |
| Author/s |
author: Patrizio Giacomini Matteo Allegretti Gennaro Ciliberto Laura Conti |
| Publication date | March 5, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |